495 Trial of SNX281, a systemically delivered small molecule STING agonist, in solid tumors and lymphomas
oleh: Judy Wang, Gerald Falchook, Johanna Bendell, Meghana Kulkarni, Melissa Johnson, Salah Nabhan, Peter Sandy, Ololade Dosunmu, Humphrey Gardner
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.